Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices 19717 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on January 

4, 2012, Meridian Medical 

Technologies, 2555 Hermelin Drive, St. 

Louis, Missouri 63144, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Morphine (9300), a basic class of 

controlled substance listed in schedule 

II. 

The company manufactures a product 

containing morphine in the United 

States. The company exports this 

product to customers around the world, 

including in Europe. The company has 

been asked to ensure that its product 

sold to European customers meets 

standards established by the European 

Pharmacopeia, which is administered 

by the Directorate for the Quality of 

Medicines (EDQM). In order to ensure 

that its product will meet European 

specifications, the company seeks to 

import morphine supplied by EDQM to 

use as reference standards. This is the 

sole purpose for which the company 

will be authorized by DEA to import 

morphine. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43, 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than May 2, 2012. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

40 FR 43745–46, all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: March 23, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–7755 Filed 3–30–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration Mallinckrodt 

LLC 

By Notice dated January 23, 2012, and 

published in the Federal Register on 

January 31, 2012, 77 FR 4831, 

Mallinckrodt LLC, 3600 North Second 

Street, St. Louis, Missouri 63147, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the 

following basic classes of controlled 

substances: 

Drug Schedule 

Phenylacetone (8501) .................. II 

Coca Leaves (9040) ..................... II 

Opium, raw (9600) ....................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substances 

for distribution to its customers, and for 

research and analytical standards. 

The company has withdrawn its 

application for registration to import the 

following drug codes: Methylphenidate 

(1724), Oxycodone (9143), 

Hydromorphone (9150), Hydrocodone 

(9193), Morphine (9300), and Fentanyl 

(9801). 

Comments and requests for hearings 

on applications to import narcotic raw 

material are not appropriate, 72 FR 3417 

(2007). Regarding all other basic classes 

of controlled substances, no comments 

or objections have been received. DEA 

has considered the factors in 21 U.S.C. 

823(a) and 952(a), and determined that 

the registration of Mallinckrodt LLC, to 

import the basic classes of controlled 

substances is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971. DEA has investigated 

Mallinckrodt LLC to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: March 23, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–7758 Filed 3–30–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application; 

Cerilliant Corporation 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on February 17, 2012, 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by letter 

to the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Drug Schedule 

4-methyl-N-methylcathinone 

(1248).

I 

3,4-methylenedioxypyrovalerone 

(7535).

I 

3,4-methylenedioxy-Nmethylcathinone (7540).I 

Desomorphine (9055) ................... I 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than June 1, 2012. 

mstockstill on DSK4VPTVN1PROD with NOTICES

19718 Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices 

Dated: March 23, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–7759 Filed 3–30–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration, 

Norac Inc. 

By Notice dated December 20, 2011, 

and published in the Federal Register 

on December 29, 2011, 76 FR 81979, 

Norac Inc., 405 S. Motor Avenue, Azusa, 

California 91702–3232, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Tetrahydrocannabinols (7370) ..... I 

Methamphetamine (1105) ............ II 

Pentobarbital (2270) ..................... II 

Nabilone (7379) ............................ II 

With regard to Gamma 

Hydroxybutyric Acid (2010), 

Tetrahydrocannabinols (7370), and 

Methamphetamine (1105) only, the 

company manufactures these controlled 

substances in bulk solely for domestic 

distribution within the United States to 

customers engaged in dosage-form 

manufacturing. 

With regard to Nabilone (7379) only, 

the company presently manufactures a 

small amount of this controlled 

substance in bulk solely to conduct 

manufacturing internal process 

development. It is the company’s 

intention once the manufacturing 

process is refined to the point that its 

Nabilone bulk product is available for 

commercial use, the company will 

export the controlled substance in bulk 

solely to customers engaged in dosageform manufacturing outside the United 

States. The company is aware of the 

requirement to obtain a DEA registration 

as an exporter to conduct this activity. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Norac, Inc. to manufacture the listed 

basic classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated Norac, 

Inc. to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 USC § 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: March 23, 2012. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2012–7750 Filed 3–30–12; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

[TA–W–81,045] 

Dow Jones & Company, Inc., Dow 

Jones Content Services Including OnSite Workers From Aerotek, Inc., 

Princeton, NJ; Amended Certification 

Regarding Eligibility To Apply for 

Worker Adjustment Assistance 

In accordance with Section 223 of the 

Trade Act of 1974, as amended (‘‘Act’’), 

19 U.S.C. 2273, the Department of Labor 

issued a Certification of Eligibility to 

Apply for Worker Adjustment 

Assistance on January 26, 2012, 

applicable to workers of Aerotek, Inc., 

working on-site at Dow Jones 

Corporation, Dow Jones Content 

Services Princeton, New Jersey. The 

workers are engaged in activities related 

to the production of digital newsletters. 

The notice was published in the Federal 

Register on February 8, 2012 (77 FR 

6590). 

At the request of the New Jersey State 

agency, the Department reviewed the 

certification for workers of the subject 

firm. New information shows that 

workers of the Princeton, New Jersey 

location of Dow Jones & Company, Dow 

Jones Content Services, including onsite workers from Aerotek were engaged 

in activities supporting the production 

of digital newsletters, both experienced 

worker separations during the relevant 

time period due to the shift in the 

production of digital newsletters to 

Sophia, Bulgaria. 

Accordingly, the Department is 

amending the certification to include 

workers of the Princeton, New Jersey 

location of Dow Jones & Company, Inc., 

Dow Jones Content Services. 

The amended notice applicable to 

TA–W–81,045 is hereby issued as 

follows: 

All workers from Dow Jones & Company, 

Inc., Dow Jones Content Services, including 

on-site workers from Aerotek, Princeton, 

New Jersey, who became totally or partially 

separated from employment on or after 

February 13, 2010, through January 26, 2014, 

and all workers in the group threatened with 

total or partial separation from employment 

on date of certification through two years 

from the date of certification, are eligible to 

apply for adjustment assistance under 

Chapter 2 of Title II of the Trade Act of 1074, 

as amended. 

Signed at Washington, DC, this 22nd day 

of March 2012. 

Elliott S. Kushner, 

Certifying Officer, Office of Trade Adjustment 

Assistance. 

[FR Doc. 2012–7795 Filed 3–30–12; 8:45 am] 

BILLING CODE 4510–FN–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

[TA–W–81,038] 

Ford Motor Company Twin Cities 

Assembly Plant Vehicle Operations 

Division Including On-Site Leased 

Workers From AEROTEK, Albers 

Mechanical, Alliedbarton, Allied 

Systems Aristeo, Autoport Collins 

Electric, Guardsmark, Great Western 

Recycling, Healthsource Solutiions, 

Kelly Services, Marsden Building 

Maintenance, Penski Logistics Ppg 

Industries, Waste Management, VMX, 

Nascote Industries, Delphi Electronics 

& Safety, Unicomm, And Pacer 

International St. Paul, MN; Amended 

Certification Regarding Eligibility To 

Apply for Worker Adjustment 

Assistance 

In accordance with Section 223 of the 

Trade Act of 1974, as amended (‘‘Act’’), 

19 U.S.C. 2273, the Department of Labor 

issued a Certification of Eligibility to 

Apply for Worker Adjustment 

Assistance on February 9, 2012, 

applicable to workers of Ford Motor 

Company, Twin Cities Assembly Plant, 

Vehicle Operations Division, St. Paul, 

Minnesota. The workers are engaged in 

activities related to the production of 

pickup trucks. The notice was 

published in the Federal Register on 

February 28, 2012 (77 FR 12083). 

At the request of the Minnesota State 

agency, the Department reviewed the 

certification for workers of the subject 

firm. New information from the 

mstockstill on DSK4VPTVN1PROD with NOTICES